Credit Agricole’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Credit Agricole’s Portfolio ARNA Stock Details ARNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-5,480	Closed	-$251K	–	701
2019 Q3	$251K	Buy	+5,480	New	+$308K	0.01%	319

Other funds holding ARNA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Credit Agricole's ARNA Position: Q4 2019 in Review

Credit Agricole sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2019, closing a stake of 5,480 shares — an estimated $251K sold.

Credit Agricole first reported a position in ARNA in Q3 2019 and held it in 1 quarter. The position peaked at $251K in Q3 2019. 226 funds tracked by Wall St. Rank hold ARNA as of Q4 2019.

Credit Agricole reported no remaining Arena Pharmaceuticals Inc position as of Q4 2019 after selling out during the quarter.
Credit Agricole sold 5,480 Arena Pharmaceuticals Inc shares in Q4 2019, an estimated $251K.
Credit Agricole first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 1 quarter.
Credit Agricole's Arena Pharmaceuticals Inc position peaked at $251K in Q3 2019.
226 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2019.

Based on Credit Agricole's 13F filing for Q4 2019, filed 12 Feb 2020.